ABOUT THIS PODCAST
This episode discusses the role of the 340B Drug Pricing Program in public health infrastructure, state and federal legislative reform of the program, the advocacy role of health systems and pharmacy teams, and the differing views shared by health systems and pharmaceutical manufacturers regarding 340B legislative reform. Listeners will learn the background and purpose of the 340B program, ongoing efforts to reform the program at the state and federal levels, and what actions are commonly undertaken to influence reform and the differing views held by 340B stakeholders.
SPEAKERS
- Kyle Robb, PharmD Director, State Policy and Advocacy, ASHP
- Mark Ogunsusi, PharmD, JD Partner, K&L Gates
